Ezra Holdings Limited (NASDAQ:EZRA) Sees Significant Decline in Short Interest

Ezra Holdings Limited (NASDAQ:EZRA) was the target of a significant decline in short interest during the month of October. As of October 30th, there was short interest totaling 7,845 shares, a decline of 82.0% from the October 15th total of 43,558 shares. Based on an average trading volume of 24,493 shares, the days-to-cover ratio is currently 0.3 days.

Ezra Price Performance

EZRA remained flat at $2.61 during trading on Friday. Ezra has a 52 week low of $1.75 and a 52 week high of $33.80. The firm’s fifty day simple moving average is $2.44 and its 200-day simple moving average is $3.89.

Wall Street Analysts Forecast Growth

EZRA has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Ezra in a research report on Friday, October 2nd. Wall Street Zen lowered shares of Ezra from a “hold” rating to a “sell” rating in a research note on Saturday, September 5th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company currently has an average rating of “Sell”.

About Ezra

Ezra is a medical imaging company focused on preventive health screening. It offers whole-body MRI scans designed to help identify potential signs of cancer and other health concerns, with results reviewed by radiologists. The company also uses artificial intelligence in its imaging process, including technology intended to make scans more efficient. Ezra’s screening services have been offered in the United States and Canada.